Hims Hers Health

Yahoo Finance • 8 days ago

YieldMax® Introduces Option Income Strategy ETF on Hims & Hers Health Inc. (HIMS)

CHICAGO, MILWAUKEE and NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- YieldMax® ETFs is excited to announce the launch today of the following ETF: YieldMax® HIMS Option Income Strategy ETF (NYSE: HIYY) HIYY seeks to generate current inco... Full story

Yahoo Finance • 10 days ago

Notable healthcare headlines for the week: Novo Nordisk, Hims & Hers and UnitedHealth in focus

Wall Street finished the week on a strong note as all three major market averages tagged record levels on Friday. For the week, the Nasdaq (COMP:IND), S&P 500 (SP500), and Dow (DJI) rose by 2.21%, 1.22%, and 1.05%, respectively. The S&P... Full story

Yahoo Finance • 12 days ago

Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.5% in the morning session after investors focused on the company's strong growth prospects, which appeared to overshadow recent regulatory challenges. Th... Full story

Yahoo Finance • 13 days ago

Stock market today: S&P 500, Nasdaq slip as Federal Reserve ushers in first rate cut of 2025

US stocks closed mixed on Wednesday after the Federal Reserve ushered in the first US interest rate cut of 2025. Fed officials voted in favor of a 25 basis point reduction, a move highly anticipated by the market, following the central ban... Full story

Yahoo Finance • 14 days ago

Stock market today: Dow, S&P 500 rise as Federal Reserve ushers in first rate cut of 2025

US stocks rose on Wednesday after the Federal Reserve ushered in the first US interest rate cut of 2025. Fed officials voted in favor of a 25 basis point reduction, a move highly anticipated by the market, following the central bank's two... Full story

Yahoo Finance • 14 days ago

Stock market today: Dow, S&P 500, Nasdaq mixed as Federal Reserve ushers in first rate cut of 2025

US stocks were mixed on Wednesday after the Federal Reserve ushered in the first US interest rate cut of 2025. Fed officials voted in favor of a 25 basis point cut, a move highly anticipated by the market, following the central bank's two... Full story

Yahoo Finance • 14 days ago

Stocks to Watch Recap: Hershey, Oracle, New York Times

↗️Hershey (HSY): Shares in the chocolate maker rose 4.3% after Goldman Sachs upgraded its recommendation on the shares to buy from sell. ↘️ Hims & Hers (HIMS): Shares of the telehealth platform dropped 5. Continue Reading View Comments... Full story

Yahoo Finance • 14 days ago

Stock market today: Dow drops, S&P 500 and Nasdaq slip from records as Wall Street counts down to Fed decision

US stocks pulled back from records on Tuesday as the Federal Reserve kicked off its September policy meeting. The benchmark S&P 500 (^GSPC) and the tech-heavy Nasdaq Composite (^IXIC) slipped roughly 0.1%. The Dow Jones Industrial Average... Full story

Yahoo Finance • 14 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index adding 0.3% an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 14 days ago

Eli Lilly, Novo Nordisk rebuked by FDA for claims made in Oprah weight loss video

[FDA Headquarters - White Oak Campus] hapabapa The U.S. FDA has issued separate warning letters to Eli Lilly (NYSE:LLY [https://seekingalpha.com/symbol/LLY]) and Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) regarding claims ma... Full story

Yahoo Finance • 15 days ago

Leverage Shares Launches First 3x Single-Stock ETPs on HOOD, HIMS, UNH and Others

LONDON, Sept. 16, 2025 /PRNewswire/ -- Leverage Shares, a pioneer and leading exchange-traded product (ETP) issuer with approximately $1.5 billion in assets under management (AUM) [1], today announces the launch of 19 new ETPs on the Londo... Full story

Yahoo Finance • 15 days ago

HIMS Quantitative Stock Analysis

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy... Full story

Yahoo Finance • 16 days ago

Stocks making the biggest moves midday: Tesla, Alaska Air, Texas Instruments, Western Digital and more

Check out some of the companies making the biggest moves midday: Tesla — CEO Elon Musk disclosed he bought $1 billion worth of shares of the electric vehicle maker on Friday, helping send the stock 6% higher. On Semiconductor , Analog Devi... Full story

Yahoo Finance • 16 days ago

Musk buys Tesla, China vs. US chips, Hims: Trending Tickers

Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Tesla (TSLA) CEO Elon Musk's purchase of the EV stock, China's probe into US semiconductors, and the US Food and Drug Administration (FDA) cla... Full story

Yahoo Finance • 16 days ago

Stocks making the biggest premarket moves: Tesla, Nvidia, Gemini, Texas Instruments and more

Check out the companies making the biggest moves in premarket trading: Tesla -- CEO Elon Musk disclosed he bought $1 billion worth of shares of the EV maker on Friday, helping send the stock nearly 8% higher. Nvidia -- The dominant maker o... Full story

Yahoo Finance • 21 days ago

Trump tasks FDA to crack down on misleading drug advertising

US President Donald Trump is launching an enforcement drive against pharmaceutical companies and social media influencers who are responsible for “misleading” drug advertising. The US Food and Drug Administration (FDA) is sending thousand... Full story

Yahoo Finance • 21 days ago

Hims & Hers to launch new offerings for treating low testosterone in men

[Glass molecular structure] Jonathan Kitchen Hims & Hers Health (NYSE:HIMS [https://seekingalpha.com/symbol/HIMS]) is set to introduce new offerings for men experiencing low testosterone this Wednesday, according to Bloomberg News. The i... Full story

Yahoo Finance • 22 days ago

HIMS Crosses Above Average Analyst Target

In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $15.18, changing hands for $15.51/share. When a stock reaches the target an analyst has set, the analyst lo... Full story

Yahoo Finance • 26 days ago

FDA targets illegal imported GLP-1 ingredients

[Ozempic Insulin injection pen] CR/iStock via Getty Images The U.S. FDA has begun a crackdown on illegally imported active pharmaceutical ingredients used to make GLP-1 weight loss drugs. Although Novo Nordisk (NVO [https://seekingalpha.... Full story

Yahoo Finance • 27 days ago

Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms

We recently published 10 Power Stocks Crushing Wall Street — 7 at All-Time Highs. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best performers on Wednesday. Hims & Hers snapped a two-day losing streak on Wednesday, adding 7.06 perce... Full story